MedTrace Logo

Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia

NCT01119586 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2016-07-11

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood or tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in DNA samples from patients with newly diagnosed high-risk acute lymphoblastic leukemia.

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

genetic linkage analysis

GENETIC

microarray analysis

GENETIC

nucleic acid sequencing

GENETIC

polymerase chain reaction

GENETIC

polymorphism analysis

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Todd E. Druley, MD · St. Louis Children's Hospital

Eligibility

Min Age
1 Year
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01119586 on ClinicalTrials.gov